Information for Respimat® patients, carers and members of the public. Are you a healthcare professional? Visit our healthcare professional site

The Respimat® inhaler is used in 3 different products


respimat seperator

Spiolto® Respimat®

What Spiolto® Respimat® is and what it is used for

What Spiolto® Respimat® is

Spiolto® Respimat® contains two active substances called tiotropium and olodaterol. These belong to a group of medicines called long-acting bronchodilators. Tiotropium belongs to the subgroup of anticholinergics; olodaterol belongs to the subgroup of long acting beta2 agonists

What Spiolto® Respimat® is used for

Spiolto® Respimat® helps adult patients who have chronic obstructive pulmonary disease (COPD) to breathe more easily. COPD is a long-term lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema.

Like all medicines, this medicine can cause side effects, although not everybody gets them. For more information, follow this link.

This page is designed for information and reference purposes and is not intended to replace the advice of a healthcare professional (HCP). Consult your doctor or suitably trained HCP if you have any questions or concerns regarding your health conditions or medications, and report any side effects to them immediately. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard
respimat seperator

Spiriva® Respimat®

What Spiriva® Respimat® is and what it is used for

What Spiriva® Respimat® is

Spiriva® Respimat® contains the active ingredient tiotropium which is a long-acting bronchodilator (long-acting muscarinic antagonist).

What Spiriva® Respimat® is used for

Spiriva® Respimat® helps people with the following conditions to breathe more easily:

  • Chronic obstructive pulmonary disease (COPD), a long-term lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema.
  • Asthma, a long-term disease characterised by airway inflammation and narrowing of the airways.

Like all medicines, this medicine can cause side effects, although not everybody gets them. A common side effect that may be experienced when using Spiriva Respimat is dry mouth.

This page is designed for information and reference purposes and is not intended to replace the advice of a healthcare professional (HCP). Consult your doctor or suitably trained HCP if you have any questions or concerns regarding your health conditions or medications, and report any side effects to them immediately. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard
respimat seperator

Striverdi® Respimat®

What Striverdi® Respimat® is and what it is used for

What Striverdi® Respimat® is

Striverdi® Respimat® contains the active ingredient olodaterol which is a long-acting bronchodilator (long-acting beta2 agonist).

What Striverdi® Respimat® is used for

Striverdi® Respimat® helps adult patients who have chronic obstructive pulmonary disease (COPD) to breathe more easily. COPD is a long-term lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema.

Like all medicines, this medicine can cause side effects, although not everybody gets them. For more information, follow this link.

This page is designed for information and reference purposes and is not intended to replace the advice of a healthcare professional (HCP). Consult your doctor or suitably trained HCP if you have any questions or concerns regarding your health conditions or medications, and report any side effects to them immediately. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard

This black triangle indicates that this medicine is subject to additional monitoring, which means that all side effects will be checked really closely. This will allow quick identification of new side effects of your medicine. You can help by reporting any side effects you may experience by using the details below in the footer

NP-GB-100352 V3 – July 2021
Please note that this website is designed for information and reference purposes only. It is not intended to replace the advice of a healthcare professional. You should consult your doctor or another suitably trained healthcare professional if you have any questions or concerns regarding your health conditions or medications, and report any side effects to them immediately.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via The Yellow Card Scheme at www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
NP-GB-100348 V3 - July 2021